US 10,240,127 B2Granted

Exosomes from clonal progenitor cells

AssigneeReCyte Therapeutics, Inc.

InventorsDana Larocca, Mohammad Hassanipour, Paola A. Bignone

Life of this patent

Estimating the term…

Abstract

The invention provides methods, compositions, uses and kits relating to exosomes isolated from progenitor cells.

Claims20

Dependent claims

An exosome isolated from an expanded clonal progenitor cell line, wherein said expanded clonal progenitor cell line is positive for the expression of PCDHB2.

Dependencies are inferred from the claim text.

Facts

Application: 14/748,215Filed 23 Jun 2015 · us provisional application
Priority: 3 Jul 2014
Published: US 2016/0108368 A121 Apr 2016
Granted: 26 Mar 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C12N 5/0692
Vascular Endothelial cells: stem cells; Progenitor cells; Precursor cells
A61K 35/44
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically…:…
C12N 2506/02
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells: from embryonic cells
C12N 2506/1353
From mesenchymal stem cells: from bone marrow mesenchymal stem cells

Family

Application62/020,869Us provisional application · filed 3 Jul 2014
US 2016/0108368 A1Pre-grant publication · published 21 Apr 2016
US 10,240,127 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results